The biggest crisis in the future of healthcare has nothing to do with the kind of issues that politicians talk about, such as payment systems and accessibility. Since cost-effective solutions to tragic and costly conditions like heart disease, dementia, diabetes, and cancer depend on bringing to market new treatments that rely upon genomics, nanotechnology, and molecular biology, the biggest problem is that at least half of the research money we invest in them is wasted. How can this be? What are the implications? What are the solutions? We’ll show you.